Influvac Tetra 2025/2026 Vaccine is a quadrivalent influenza vaccine designed to provide immunity against four different strains of the influenza virus, helping to protect individuals from seasonal flu infections. Administered as an intramuscular injection by healthcare professionals just before the flu season, this vaccine is formulated to target the most common influenza virus strains predicted for the 2025/2026 season. It is especially recommended for elderly adults, individuals with chronic health conditions such as diabetes, heart failure, kidney failure, or COPD, and children over six months of age. The vaccine stimulates the immune system to develop protective antibodies, reducing the severity and risk of influenza infections. While mild side effects such as headache, muscle pain, and swelling at the injection site may occur, these typically resolve quickly. Regular annual vaccination with Influvac Tetra is important due to the frequent mutation of flu virus strains, ensuring effective protection throughout the flu season. This vaccine is not intended for treatment of existing influenza infections and does not protect against avian flu or the common cold. Pregnant or breastfeeding women should consult their healthcare provider before vaccination. Overall, Influvac Tetra 2025/2026 Vaccine is a vital preventative healthcare product for managing influenza risk in vulnerable populations and the general public.
Key Features
| Features | Description |
|---|---|
| Vaccine Type | Quadrivalent (four-strain) influenza vaccine |
| Targeted Flu Season | 2025/2026 |
| Administration Method | Intramuscular injection |
| Dosage | Single annual dose |
| Target Groups | Elderly, chronic disease patients, children over 6 months |
| Immunity Provided | Protection against four influenza virus strains |
| Side Effects | Mild; headache, muscle/joint pain, injection site soreness |
| Contraindications | High fever illness, prior allergic vaccine reaction |
| Pregnancy/Breastfeeding | Consult healthcare provider before use |
| Not Effective Against | Avian flu and common cold |
| Attributes | Description |
|---|---|
| Vaccine Composition | Inactivated influenza virus strains per WHO recommendations |
| Storage Conditions | 2°C to 8°C (refrigerated) |
| Shelf Life | Typically 1 year (check packaging) |
| Packaging | Single-dose pre-filled syringes or multi-dose vials |
| Manufacturer | Available from licensed pharmaceutical manufacturers |
| Indications | Prevention of seasonal influenza infection |
| Contraindications | Known hypersensitivity to vaccine components |
| Patient Age Range | 6 months and above |
| Administration Site | Muscle (typically deltoid or anterolateral thigh) |
| Immunization Schedule | Annual vaccination prior to influenza season |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Influvac Tetra 2025/2026 protects against four different strains of the influenza virus, making it a quadrivalent vaccine.
No, Influvac Tetra is recommended for children aged 6 months and older.
Pregnant or breastfeeding women should consult their healthcare provider before receiving Influvac Tetra.
No, it does not prevent illness from avian flu (bird flu) or common colds, only seasonal influenza strains.
Vaccination should be postponed if the patient has an illness with a high temperature until recovery.
Yes, annual vaccination is recommended as flu virus strains frequently change from year to year.
Common side effects include headache, muscle pain, joint pain, injection site swelling or pain, tiredness, and slight fever.
Country Of Origin: India
Influvac Tetra 2025/2026 Vaccine is given as an injection into a muscle by a doctor or nurse. It is usually given just before the cold season when the flu virus begins to increase. Normally, only one injection is required to protect you for a year. You should have the vaccination each year because different new strains of the flu virus emerge frequently and different vaccines are developed. It is especially important to have this vaccine if you are elderly or have chronic health problems such as diabetes, heart failure, kidney failure, or chronic obstructive pulmonary disease (COPD). It is also recommended for young children over 6 months of age.
Inclusive of all taxes
You Save: 0
Ahmedabad , India
Service Provider , Manufacturer, Professional Services, Contractor, Brand Owner, Distributor, Exporter, Wholesaler, Startup
GST- 24aalck4617k1zb
